See Remarks · Arcutis Biotherapeutics, Inc. · Common Stock
Side
SELL
Value
$733K
Shares
29.1K
Price
$25.16
Executed
Nov 6, 2025
Disclosed
Nov 10, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 10, 2025 disclosed
ARQT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
6 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Edwards Larry Todd filed this Form 4 reporting a open-market sale of ARQT on Nov 6, 2025. It became public on Nov 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
Edwards Larry Toddcik:0001994805
Issuer
Arcutis Biotherapeutics, Inc.cik:0001787306
Revision history · 0
No field has changed since this record was first ingested.
